Expansion channels Leverage recent U S retail launches in CVS and Walmart for immediate cross-sell opportunities with wound care and dermatology portfolios; explore placement in pharmacies and big-box retailers internationally as HOCl solutions gain consumer trust.

Dermatology demand capitalize on the new dermatology product line under Aquanil for sensitive skin to target dermatology clinics, aesthetics practices, and consumer retail channels seeking HOCl-based soothing formulations with broad patient appeal.

Regulatory readiness With a new SVP of Regulatory, Quality and Product Development appointment, position higher-value, compliant product expansions (international, OTC and Rx-adjacent lines) to distributors and private label partners seeking faster time-to-market.

Wound care leadership The proven Microcyn HOCl technology offers a competitive edge in wound care, diaper rash, burns, and related skin conditions; pursue partnerships with hospitals, long-term care facilities, and school health programs to scale adoption.

International growth Recent UK acne line launch signals appetite for international expansion; target key regions with HOCl trust benefits, align with wholesalers and e-commerce platforms to accelerate global footprint and diversify revenue streams.